Effect of weight reduction on glycated haemoglobin in weight loss trials in patients with type 2 diabetes
- PMID: 28417575
- DOI: 10.1111/dom.12971
Effect of weight reduction on glycated haemoglobin in weight loss trials in patients with type 2 diabetes
Abstract
Aim: To quantify the effect of weight loss on glycated haemoglobin (HbA1c) at group level, based on data from published weight loss trials in overweight and obese patients with type 2 diabetes (T2D).
Methods: A systematic literature search in MEDLINE, EMBASE and Cochrane CENTRAL (January 1990 through December 2012) was conducted to identify prospective trials of energy-reduced diets, obesity drugs or bariatric surgery in adult, overweight and obese patients with T2D. Based on clinical data with follow-up from 3 to 24 months, a linear model was developed to describe the effect of weight reduction on HbA1c.
Results: The literature search identified 58 eligible articles consisting of 124 treatment groups and 17 204 subjects, yielding a total of 250 data points with concurrent mean changes from baseline in weight and HbA1c. The model-based analyses indicated a linear relationship between weight loss and HbA1c reduction, with an estimated mean HbA1c reduction of 0.1 percentage points for each 1 kg of reduced body weight for the overall population. Baseline HbA1c was a significant covariate for the relationship between weight loss and HbA1c: high HbA1c at baseline was associated with a greater reduction in HbA1c for the same degree of weight loss. The collected trial data also indicated weight-loss-dependent reductions in antidiabetic medication.
Conclusions: At group level, weight loss in obese and overweight patients with T2D was consistently accompanied by HbA1c reduction in a dose-dependent manner. The model developed in the present study estimates that for each kg of mean weight loss, there is a mean HbA1c reduction of 0.1 percentage points. HbA1c-lowering is greater in populations with poor glycaemic control than in well controlled populations with the same degree of weight loss. This summary of data from previous trials regarding the effect of weight reduction on HbA1c may be used to support the design and interpretation of future studies that aim to demonstrate the efficacy of weight loss interventions for T2D treatment.
Keywords: HbA1c; glycaemic control; obesity; systematic review; type 2 diabetes; weight loss.
© 2017 John Wiley & Sons Ltd.
Similar articles
-
Efficacy and acceptability of very low energy diets in overweight and obese people with Type 2 diabetes mellitus: a systematic review with meta-analyses.Diabet Med. 2016 May;33(5):580-91. doi: 10.1111/dme.13005. Epub 2015 Dec 12. Diabet Med. 2016. PMID: 26490082 Review.
-
The effect of macronutrients on glycaemic control: a systematic review of dietary randomised controlled trials in overweight and obese adults with type 2 diabetes in which there was no difference in weight loss between treatment groups.Br J Nutr. 2015 Nov 28;114(10):1656-66. doi: 10.1017/S0007114515003475. Epub 2015 Sep 28. Br J Nutr. 2015. PMID: 26411958 Free PMC article. Review.
-
Effect of orlistat on glycaemic control in overweight and obese patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials.Obes Rev. 2015 Dec;16(12):1071-80. doi: 10.1111/obr.12318. Epub 2015 Sep 8. Obes Rev. 2015. PMID: 26345590 Review.
-
Lifestyle weight-loss intervention outcomes in overweight and obese adults with type 2 diabetes: a systematic review and meta-analysis of randomized clinical trials.J Acad Nutr Diet. 2015 Sep;115(9):1447-63. doi: 10.1016/j.jand.2015.02.031. Epub 2015 Apr 29. J Acad Nutr Diet. 2015. PMID: 25935570 Review.
-
Effectiveness of lifestyle-based weight loss interventions for adults with type 2 diabetes: a systematic review and meta-analysis.Diabetes Obes Metab. 2015 Apr;17(4):371-8. doi: 10.1111/dom.12430. Epub 2015 Jan 14. Diabetes Obes Metab. 2015. PMID: 25523815 Review.
Cited by
-
The impact of major depressive disorder on glycaemic control in type 2 diabetes: a longitudinal cohort study using UK Biobank primary care records.BMC Med. 2024 May 29;22(1):211. doi: 10.1186/s12916-024-03425-9. BMC Med. 2024. PMID: 38807170 Free PMC article.
-
Real-World Assessment of Personalized Approach With Voglibose Fixed-Dose Combination in Type 2 Diabetes Mellitus.Cureus. 2024 Apr 3;16(4):e57494. doi: 10.7759/cureus.57494. eCollection 2024 Apr. Cureus. 2024. PMID: 38707131 Free PMC article.
-
Trends of HbA1c and BMI in People with Type 2 Diabetes: A Japanese Claims-Based Study.Diabetes Ther. 2024 Apr;15(4):801-817. doi: 10.1007/s13300-024-01543-4. Epub 2024 Feb 24. Diabetes Ther. 2024. PMID: 38401022 Free PMC article.
-
Impact of Weight Change on Glycemic Control and Metabolic Parameters in T2D: A Retrospective US Study Based on Real-World Data.Diabetes Ther. 2024 Feb;15(2):409-426. doi: 10.1007/s13300-023-01511-4. Epub 2023 Dec 1. Diabetes Ther. 2024. PMID: 38038898 Free PMC article.
-
The role of SGLT2i in attenuating residual cardiovascular risk through blood pressure-lowering: mechanistic insights and perspectives.Front Clin Diabetes Healthc. 2023 Sep 26;4:1243530. doi: 10.3389/fcdhc.2023.1243530. eCollection 2023. Front Clin Diabetes Healthc. 2023. PMID: 37822556 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical